XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 10,229,646 $ 22,397,812
Short-term investments available-for-sale, at fair value 15,187,672 6,298,075
Accounts receivable 1,904,534 1,588,767
Inventory, net of allowance of $16,393 at September 30, 2021 and $26,052 at December 31, 2020 2,340,766 1,492,126
Prepaid expenses and other 2,082,410 1,094,273
Total current assets 31,745,028 32,871,053
Operating lease right-of-use assets 1,444,348 1,009,097
Property and equipment, net 1,219,190 1,227,402
Other non-current assets 98,828 90,356
Total assets 34,507,394 35,197,908
Current liabilities:    
Accounts payable 1,145,868 1,348,762
Accrued liabilities 1,609,001 1,459,878
Contract liabilities – current 213,462 185,083
NuvoGen obligation – current 530,657 512,729
Current portion of long-term debt 4,167,107 3,022,139
Operating lease liabilities – current 398,313 685,220
Other current liabilities 17,558 22,563
Total current liabilities 8,081,966 7,236,374
NuvoGen obligation - non-current, net of discount 4,072,831 4,479,396
Long-term debt, net of current portion, discount and debt issuance costs 6,309,416 8,568,308
Operating lease liabilities - non-current 1,055,984 368,682
Other non-current liabilities 99,825 60,488
Total liabilities 19,620,022 20,713,248
Commitments and Contingencies (Note 15)
Stockholders’ equity:    
Series A convertible preferred stock, $0.001 par value; 23,770 shares authorized, issued and outstanding at September 30, 2021 and December 31, 2020 24 24
Common stock, $0.001 par value; 26,666,667 shares authorized at September 30, 2021 and December 31, 2020, 7,513,733 shares issued and outstanding at September 30, 2021 and 5,199,997 shares issued and outstanding at December 31, 2020 7,514 5,200
Additional paid-in-capital 218,018,993 205,661,999
Accumulated other comprehensive income 2,583 5,298
Accumulated deficit (203,141,742) (191,187,861)
Total stockholders’ equity 14,887,372 14,484,660
Total liabilities and stockholders' equity $ 34,507,394 $ 35,197,908